Tracking the hidden cost of cancer treatment: nerve damage
NCT ID NCT06657157
Summary
This study aims to understand how often and how severely nerve damage occurs in bladder cancer patients receiving a specific two-drug treatment. Researchers will follow 80 patients receiving enfortumab vedotin and pembrolizumab to track this side effect, its impact on daily life, and how it affects treatment plans. The goal is to gather information to better manage this complication in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Urology, Klinikum rechts der Isar, Technical University Munich
RECRUITINGMunich, Bavaria, 81675, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Urology, LMU University Hospital, Ludwig-Maximilians-University Munich
RECRUITINGMunich, Bavaria, 81377, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Urology, University Hospital of Würzburg
RECRUITINGWürzburg, Bavaria, 97080, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Urology, University Hosptial Augsburg
RECRUITINGAugsburg, Bavaria, 86156, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.